BioSpace News Archive

Drug Development

Kadmon to Present Initial Safety Data from Phase 1 Study of KD033 at the 2021 American Society of Clinical Oncology Annual Meeting

Results Demonstrate KD033 was Well Tolerated in All Patients through Initial Dose Cohorts, Allowing for Continuation of Dose Escalation

May 19, 2021
·
7 min read
Pharm Country

IMBRUVICA® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukemia Demonstrates High Rates of Disease Control

Janssen presents new data at ASCO showing efficacy of IMBRUVICA® plus venetoclax in previously untreated patients with chronic lymphocytic leukemia, and up to seven-year follow-up results on progression-free and overall survival benefits with single-agent IMBRUVICA®

May 19, 2021
·
17 min read
BioForest

Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual Meeting

- Alpine to hold Investor Event on Friday, June 4 at 7:00pm ET - - Program abstracts are now live on the ASCO website -

May 19, 2021
·
5 min read
Pharm Country

Long-term Data on Vitrakvi® (larotrectinib) Further Demonstrate Strong Clinical Profile in Patients with TRK Fusion Cancer Regardless of Tumor Type and Age

Bayer to present new data across four distinct analyses showcasing the consistent, long-term clinical profile for Vitrakvi® across TRK fusion cancer patients of all ages and multiple tumor types.

May 19, 2021
·
14 min read
MorphoSys to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual Meeting

MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that new data from the tafasitamab (Monjuvi (R) ) development program will be presented at the upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting from June 4-8, 2021.

May 19, 2021
·
11 min read
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting

Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting Early clinical data for investigational oral selective estrogen receptor (SERD), amcenestrant, show potential to become a new endocrine backbone therapy in ER+ HER2- breast cancer

May 19, 2021
·
9 min read
Bio NC

Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore

Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore.

May 19, 2021
·
4 min read
Drug Development

Sorrento Reports Positive Initial Result in Dosing of First Enbrel-Non-Responding Rheumatoid Arthritis Patient With the Sofusa® Lymphatic Drug Delivery Device

Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the required dosing (as compared to traditional systemic or subcutaneous injections or infusions).

May 19, 2021
·
9 min read